Thursday, March 22, 2012

Emerson Consultants, Inc. is HIRING!!!

Emerson Consultants, Inc. is hiring a Regulatory Associate!!!

The Regulatory Associate is responsible for activities which lead to, and maintain regulatory approval to market devices. Additionally, the Associate is responsible for assessment of device changes for regulatory implications.

KEY RESPONSIBILITIES
• Develop strategies for regulatory approval of medical devices.
• Coordinate submission activities for a variety of device regulatory approvals including: US premarket approvals, international design dossiers, post-approval reports, export certificates, clinical trial exemptions and establishment registrations and listings.
• Communicate submission and/or advertising and promotion requirements to product development teams.
• Research regulatory requirements for assigned geographies. Monitor emerging trends and integrate new requirements into department procedures and toolkits.
• Coordinate IFU development activities.
·         Process change orders.

To apply send resume to :  cathyc@emersonconsultants.com

Tuesday, January 18, 2011

Emerson Consultants, Inc. Selected to Provide US Government with Information on Breakthrough Medical Technologies


Minnetonka, Minn. (January 18, 2011) - The ECRI Institute has awarded Minnetonka-based Emerson Consultants, Inc., a multi-year subcontract to assist them in establishing a national resource for the U.S. Government Department of Health and Human Services to track new medical technologies. The Healthcare Horizon Scanning System is being created specifically for the Department’s Agency for Healthcare Research and Quality (AHRQ) to establish a process for identifying, tracking, and monitoring new medical devices, drugs, procedures, and health care delivery innovations.

"We are looking forward to collaborating with ECRI on this project for the US Government," said Barb Peterson, President and CEO of Emerson Consultants. "The Healthcare Horizon Scanning System will provide the government with critical information on new medical technologies so they can understand the potential benefits for the US public and incorporate this knowledge into setting priorities for comparative effectiveness research to improve healthcare in this country."